← SynDRA
ZD-4190 FREE BASE
SynDRA canonical compound SYN0001520 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EGFR | KDR |
|---|
| Mechanism of action | antitumor agent |
|---|
| Indication | gastric adenocarcinoma |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- KDR INHIBITOR
- Vascular endothelial growth factor receptor 2 inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- FGFR1
- FLT1
- PDGFRB
- CDK2
- ERBB2
- IGF1R
- PDPK1
- TEK
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
Cross-references
Synonyms
- Zd-4190
- ZD4190
- RefChem:934491
- ZD-4190?
- C19H16BrFN6O2
- SCHEMBL173259
- BDBM4651
- orb1301760
- SCHEMBL29729304
- NRA59962
- HY-U00002
- s6543
- AKOS040758760
- CS-6801
- AC-38134
- MS-28405
- T5475
- N16890
- SCHEMBL29363192
- DB-405810
- CS-0077325
- T29209
- N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[2-(triazol-1-yl)ethoxy]quinazolin-4-amine hydrochloride
- ZD-4190 (hydrochloride)
- CHEMBL3544937
- orb1698925
- AKOS040749836
- ZD4190 HCl
- ZD4190 hydrochloride
- AC1OCFDK
- ZD-4190
Look up ZD-4190 FREE BASE in the interactive SynDRA portal →